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Abstract : The mandibular condyle formation during temporomandibular joint (TMJ) development 
exhibits endochondral bone formation, and the elongation process is dependent on the normal car-
tilage proliferation and differentiation.  Retinoids are important for maturation of growth-plate 
chondrocytes, but the identity of their downstream effectors remains unclear.  In this study, we 
carried out a series of studies at the cellular, biochemical, and molecular levels to determine 
whether, and if so how, retinoid signaling is related to the expression and function of Indian hedge-
hog (Ihh) in chondrocyte proliferation.  First we analyzed the RA receptor (RAR) and Ihh expres-
sion pattern in E18 mandibular condyle.  RARα and RARβ mRNA were characterized in the per-
ichondrium around the condyle, whereas RARγ mRNA was expressed in the immature and 
prehypertrophic chondrocytes and the expression was overlapped with Ihh gene expression.  Next 
we established a high-density culture model of chick cephalic chondrocytes in the prehypertrophic 
stage.  We found that all-trans retinoic acid (RA) induced Ihh mRNA gene expression in this sys-
tem.  The RA pan-antagonist Ro 41-5253 inhibited both endogenous and RA-induced Ihh mRNA in 
a dose-dependent manner.  The Ihh mRNA expression induced by RA required de novo protein syn-
thesis, and was mediated by RARγ.  Immunoblots showed that the prehypertrophic chondrocytes 
contained sizable levels of phosphorylated p38 mitogen-activated protein (MAP) kinase that were 
time- and dose-dependently increased by the RA treatment.  Experimental p38 inhibition led to a 
severe drop in baseline and RA-stimulated Ihh expression.  Exogenous recombinant Ihh stimulated 
the proliferation of proliferating chondrocytes, whereas RA inhibited the proliferation of these 
chondrocytes through p38 MAPK.  Retinoids appear to play a primary role in controlling both the 
expression and function of Ihh in prehypertrophic chondrocytes and do so via p38 MAP kinase.
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Introduction
 The temporomandibular joint (TMJ) is a com-
plex skeletal structure that mediates, and is es-
sential for, normal functioning of the jaw1,2.  The 
mandibular condylar condensation differentiates 
into cartilage, forms a growth plate-like structure, 
and becomes distinguishable into four distinct 
portions along its main axis : a ﬁbrous cell layer, a 
polymorphic progenitor cell layer, a zone of ﬂat-
tened chondrocytes, and a zone of hypertrophic 
chondrocytes3.  The so-structured condyle exhibits 
fairly rapid growth and elongation toward the dif-
ferentiating temporal bone.  Of interest, this elon-
gation process is due to appositional growth at its 
apical end in which chondroprogenitor cells in the 
polymorphic cell layer undergo chondrogenesis 
and the newly differentiated chondrocytes become 
incorporated into the underlying condylar carti-
laginous tissue4.  With time, the condylar chondro-
cytes in the lower zones undergo maturation and 
hypertrophy and are replaced by endochondral 
bone connecting to the condylar process5,6.
 Indian hedgehog (Ihh) is a member of a power-
ful family of secreted signaling proteins.  Ihh is 
expressed by a restricted number of cell types and 
organs during embryogenesis, including prehyper-
trophic chondrocytes in growth plates and in man-
dibular condylar cartilage of developing endochon-
dral skeletal structures7.  Ihh expression by 
prehypertrophic chondrocytes has stimulated a 
great deal of interest and research activity owing 
to the ﬁnding that the growth plate is of critical 
importance for skeletal development and growth. 
The perichondrial tissue adjacent to the Ihh-ex-
pressing prehypertrophic chondrocytes is the site 
of initiation of intramembranous bone collar de-
velopment8.  Reduced chondrocyte proliferation 
was subsequently demonstrated also in mouse 
embryos in which the transmembrane protein 
Smoothened was conditionally deleted in carti-
lage, strengthening the conclusion that Ihh is an 
important regulator of chondrocyte proliferation 
in the growth plate9.  These studies together with 
other ones have led to the important overall con-
clusion that Ihh has multiple roles and exerts in-
ﬂuence in the proliferative zone as well as in the 
surrounding perichondrial tissues10–12. 
 Retinoids are powerful signaling molecules that 
regulate a number of processes and steps in the 
developing embryo13.  For example, locally re-
leased retinoic acid repatterns ﬁrst branchial arch 
cartilage14.  Evidence supporting the role of retin-
oids in skeletogenesis dates back decades, coming 
from nutritional studies on the effects of hypo- 
and hypervitaminosis A in animals and hu-
mans15,16.  Subsequent identiﬁcation of retinoic 
acid nuclear receptors (RARα, RARβ, and RARγ) 
and analysis of the effects of single and double 
RAR gene ablations in mice provided more com-
pelling evidence that a normal complement of 
RARs and retinoid signaling are required for skel-
etogenesis17,18.  Recent studies have provided 
strong evidence that retinoids are involved in, and 
required for, chondrocyte maturation and ossiﬁca-
tion.  However, the downstream effectors and 
mechanisms of retinoid signaling action in those 
processes remain largely unknown. 
 In this study, we show that RA-speciﬁc induc-
tion of Ihh expression by prehypertrophic chondro-
cytes was mediated via RARγ and required p38 
MAPK activity.  Furthermore, p38 MAPK induced 
by RA acted via Ihh as a positive, and directly as a 
negative, regulator of chondrocyte proliferation.
Materials and Methods
1. Materials
 The materials and their sources were as follows : 
Dulbecco-Modiﬁed high-glucose Eagle’s Medium 
(DMEM) and other tissue culture components, 
from GIBCO-BRL (Gaithersburg, MD, USA) ; de-
ﬁned FBS, from Hyclone (Logan, UT, USA) ; iso-
topes, from Amersham Pharmacia Biotech. ;  all-
trans-retinoic acid (RA) and type 1-S collagenase, 
from Sigma (St. Louis, MO, USA) ; TRIZOL, from 
Life Technologies (Rockville, MD, USA) ; X-ray 
ﬁlms, from Kodak (Rochester, NY, USA) ; Immobi-
lon-P membranes, from Millipore ; BCA protein as-
say kit, from Pierce ; PD98059 and SB203580, 
from Calbiochem (La Jolla, CA, USA) ; and anti-
bodies, from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA).  The RAR pan-antagonist Ro 
41-5253 was generously provided by Hoffmann-
LaRoche (Basel, Switzerland).  Chick rIhh-N (ami-
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no acids 24-198) was prepared in baculovirus- in-
fected insect cells12. 
2. In situ hybridization
 For in situ hybridization, parafﬁn-embedded se-
rial tissue sections were pretreated with 10 μg/ml 
proteinase K (Sigma) for 10 min at RT, postﬁxed 
in 4% paraformaldehyde, washed with phosphate 
buffered saline containing 2 mg/ml glycine, and 
treated with 0.25% acetic anhydride in trietha-
nolamine buffer19.  Sections were hybridized with 
antisense or sense 35S-labeled probes (approxi-
mately 1× 106 DPM/section) at 50℃ for 16 hr. 
Mouse cDNA clones were as follows : RARα (nt. 
2025-2819. NM_009024), RARβ (nt. 1516-2332. 
NM_011243), RARγ (nt. 1558-2232. NM_011244), 
Ihh (nt. 897–1954 ; MN_010544), and osteopontin 
(nt. 1–267 ; AF515708).  After hybridization, slides 
were washed with 2 standard saline citrate (SSC) 
containing 50% formamide at 50℃ , treated with 
20 μg/ml RNase A for 30 min at 37℃, and washed 
three times with 0.1× SSC at 50℃ for 10 min/
wash.  Sections were dehydrated with 70, 90, and 
100% ethanol for 5 min/step, coated with Kodak 
NTB-3 emulsion diluted 1 :1 with water, and ex-
posed for 10 to 14 days.  Slides were developed 
with Kodak D-19 at 20℃ and stained with hema-
toxylin.  Dark- and bright-ﬁeld images were cap-
tured using a digital camera.  
3. Chondrocyte Cultures
 Cell populations rich in resting chondrocytes 
were isolated from the caudal portion of day-17 
chick embryo sterna, whereas populations rich in 
proliferating and early hypertrophic chondrocytes 
were isolated from peripheral and core portions of 
the cephalic sternal region20.  Dissected tissues 
were incubated for 1 h at 37℃ in saline containing 
0.1% type 1-S collagenase, and the cells released 
after this incubation were discarded, because they 
consisted mainly of perichondrial and blood cells. 
The remaining tissues were incubated in a fresh 
mixture of 0.25% trypsin and 0.1% collagenase for 
3 h, after which time the tissues were completely 
digested.  Freshly isolated chondrocytes were plat-
ed at 1.5-2.0× 106 cells/60-mm dish in complete 
DMEM medium containing 10% FBS, 2 mM L-
glutamine, and 50 U/ml penicillin, and 50 U/ml 
streptomycin.  During the ﬁrst 2 days, the cul-
tures received 4 U/ml of testicular hyaluronidase 
to minimize cell detachment.  They were fed every 
other day and subcultured at weekly intervals by 
trypsinization.  Day-7 semiconﬂuent cultures were 
shifted to and kept for 24 h in DMEM high-glucose 
medium containing 0.5% FBS and were treated 
during the subsequent 24 h with speciﬁed concen-
trations of RA, Ro 41-5253, PD98059, SB203580, 
or combinations of these reagents, as required in a 
given experiment. 
4. Northern blot analysis
 Total RNA was prepared from cultured chick 
chondrocytes by using TRIZOL reagent.  Northern 
blot analysis was carried out by the standard pro-
cedure.  Brieﬂy, 20 μg of total RNA was denatured 
by glyoxalation and size-fractionated by gel elec-
trophoresis in 1% agarose gels at 20 μg/lane, and 
transferred to a membrane by capillary blotting, 
as described previously20.  The blots were stained 
with 0.04% methylene blue to verify that each 
sample had been transferred efﬁciently.  Chick 
cDNA probes used, a RARγ subclone prepared 
from full-length (1,230 kb) RARγ, a 0.197-kb chick 
collagen X cDNA clone, and Ihh clone encoding 
part of the N-terminal domain21, were generated 
by the reverse transcription-polymerase chain re-
action (RT-PCR) from mRNA of chick sternal 
chondrocytes.  The PCR products were subcloned 
into the PBluescript II SK (－) and subjected to 
sequencing for identiﬁcation12.  Blots were hybrid-
ized at 42℃ for 16 h to 32P-labeled DNA probes at 
a concentration of 2.5× 106 dpm/ml of hybridiza-
tion solution containing 50% formamide, 6× SSC, 
1% SDS, 200 mg/ml sheared denatured salmon 
sperm DNA, and 10× Denhardt’s reagent.  After 
hybridization, the blots were rinsed several times 
at room temperature with 2× SSC and 0.5% 
SDS; and a ﬁnal high-stringency rinse was done 
with 0.1× SSC and 0.5% SDS at room tempera-
ture.  Blots were exposed to X-ray ﬁlms at －70℃.
5. Immunoblot analysis
 Immunoblot analysis for MAPK and activated 
MAPK was performed by using cell lysates from 
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experimental cultures.  The cells were lysed in a 
lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% 
Triton X-100, 1% NP-40, 10 mM NaF, 2 mM 
Na3VO4, 1 μg/ml leupeptin, 1 mM phenyl methyl 
sulfonyl ﬂuoride [PMSF], pH 7.4) on ice.  The 
lysates were centrifuged at 14,000 rpm for 20 min 
at 4℃, and protein concentrations in the superna-
tant were determined by conducting a BCA assay. 
A 50-μg sample of each lysate was subjected to 
12% SDS-polyacrylamide gel electrophoresis.  Fi-
nally, the proteins were then transferred to nylon 
membranes (Immobilon-P, Millipore Co.).  Bands 
for MAPK and activated MAPK were detected by 
their respective antibodies. 
6. Cell proliferation assay
 Second-passage chondrocytes were seeded in 
96-microwell plates at 2× 104 cells/well in com-
plete medium and incubated for 2 to 3 days until 
subconﬂuent.  The medium was then switched to 
DMEM containing 0.5% FBS. Twenty-four hours 
later, the cells were then treated with rIhh-N, RA 
or inhibitors for 24 hr.  Cultures were pulse-la-
beled with BrdU or 370 kBq/ml of [3H] thymidine 
(Amersham Pharmacia) during the last 2 hr of 
culture, and processed with an enzyme-linked im-
munosorbent assay BrdU assay kit (Boehringer 
Mannheim Corp) or the radioactivity was deter-
mined with a scintillation counter (Micro Beta 
Plus ; Wallac, Gaithersburg, MD, USA)12,20.  Each 
time point was measured in triplicate, and each 
assay was repeated in 3 independent experiments. 
Results
1.  RAR and Ihh gene expression in mandibu-
lar condylar cartilage 
 In the ﬁrst set of experiments, we determined 
the patterns of RAR and Ihh gene expression at E 
18 mandibular condylar cartilage by in situ hy-
bridization.  The chondrocytes had become orga-
nized into growth plate zones of ﬂat and hypertro-
phic chondrocytes, and were overlaid by typical 
ﬁbrous and polymorphic tissue layers containing 
progenitor cells (Fig. 1A).  RARα and RARβ were 
present in perichondrium around the condyle (Fig. 
1B and C), whereas RARγ was expressed in im-
mature chondrocytes and prehypertrophic chon-
drocytes in addition to the perichondrium (Fig. 
1D).  Notably, Ihh expression was considerable in 
immature chondrocytes and prehypertrophic 
chondrocytes at this stage as well (Fig. 1E), and 
Fig. 1 Histological analysis and gene expression of RARα, RARβ, RARγ, Ihh and osteopontin (OP) in condylar car-
tilage. Mandibular condyles from embryonic day E18 embryo were sectioned along their main longitudinal 
axis, and sections were stained with hematoxylin and eosin (A) or processed for in situ hybridization (B-F).
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the expression was overlapped with RARγ expres-
sion.  Osteopontin (OP) was expressed in posthy-
pertrophic and endochondral bone cells (Fig. 1F).
2. Expression of Ihh, RARγ and Type X colla-
gen mRNA during cultured chondrocyte 
differentiation  
 To investigate the cellular events occurring dur-
ing chondrocyte differentiation in mandibular con-
dylar cartilage (Fig. 1), we used chick upper sterna 
cephalic chondrocytes in high-density cultures as 
a growth plate model.  This culture system con-
tains a mixture of chondrocytes from the prehy-
pertrophic to hypertrophic zone of the growth 
plate.  Interestingly, these chondrocytes were ca-
pable of recapitulating the prehypertrophic (day 7) 
stage of the differentiation program in vitro (Fig. 
2).  In this system, the cells reached conﬂuence on 
day 7, and the Ihh mRNA level was high at that 
time and then dropped sharply by day 14.  RARγ 
mRNA was detected on day 7 whereas both RARα 
and RARβ mRNA were not detected on day 0-21 
(data not shown).  Type X collagen mRNA started 
to increase on day 14 and reached a maximum or 
plateau on day 21.  From these observations, we 
regarded the cells at day 7 as chondrocytes in the 
prehypertrophic stage. 
3.  RA-dependent modulation of Ihh expres-
sion
 Having found that Ihh was expressed on day 7, 
at the prehypertrophic stage of high-density chon-
drocyte cultures, we determined whether Ihh ex-
pression could be regulated by retinoids at that 
stage of chondrocytes in vitro.  Day-7 cultures of 
prehypertrophic chondrocytes were switched to 
low serum-containing medium and treated with 
100 nM of RA for 24 h in the absence or presence 
of different doses of its antagonist Ro 41-5253 and 
thereafter analyzed by Northern blotting.  Com-
panion cultures received antagonist alone or no 
treatment, and all cultures were processed for 
gene expression.  Whereas RA boosted Ihh expres-
sion over the control value, as expected (Fig. 3, 
lanes 4–5), increasing amounts of the antagonist 
progressively reversed the RA action, and 10－6 M 
antagonist completely blocked it (Fig. 3, lanes 
6–9).  Interestingly, treatment with antagonist 
Fig. 2 Changes in Ihh, RARγ, and type X collagen (Coll X) mRNA level 
in upper sternal core (USC) chondrocytes in vitro. Total RNA 
was isolated from chick USC chondrocyte cultures on days 0 
(primary tissue), 7, 14 and 21. Total cellular RNA was processed 
for Northern blot analysis of genes encoding Ihh (●), RARγ (■), 
and Type X collagen (▲) and quantiﬁed by densitometry.
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alone decreased endogenous Ihh expression (Fig. 3, 
lanes 1–3) compared with control values (Fig. 3, 
lane 4), indicating that endogenous expression 
was also dependent on retinoid signaling. 
4. Effects of RA on the half-life of Ihh mRNA  
 Next, the effect of RA on the stability of Ihh 
mRNA was examined.  Northern blot analyses 
were performed with addition of actinomycin D (5 
μg/ml) after 6 h of RA (100 nM) stimulation (Fig. 
4A).  In prehypertrophic chondrocytes, the half-
life of Ihh mRNA was 2.7 h in RA-treated cells. 
The Ihh mRNA decay occurred at similar rates, 
regardless of the presence or absence of 100 nM 
RA, in the presence of actinomycin D.  These ﬁnd-
ings indicate that RA did not alter the stability of 
this transcript. 
5.  Effects of cycloheximide on Ihh mRNA 
regulation 
 To elucidate whether the RA stimulation of Ihh 
expression required new protein synthesis of cy-
tokines or transcriptional factors, we treated pre-
hypertrophic chondrocytes for 2 h with a protein 
synthesis inhibitor, 10 μg/ml cycloheximide, and 
then treated them for 6 h with 100 nM RA.  Fig. 
4B shows that RA did not increase the level of Ihh 
mRNA in cephalic chondrocytes under the treat-
ment with cycloheximide.  These data suggest 
that the enhancement of Ihh mRNA by RA was 
prohibited by increased synthesis of some regula-
tory protein. 
6. Involvement of MAP kinases 
 To determine whether MAP kinases were in-
volved in the retinoid action on Ihh expression, we 
treated prehypertrophic chondrocytes with 100 
nM RA for 24 h in the absence or presence of in-
creasing concentration of PD98059, a speciﬁc in-
hibitor of MEK, or SB203580, a speciﬁc inhibitor 
of p38 MAPK.  As shown in Fig. 5, treatment with 
the p38 inhibitor reversed the RA stimulation of 
Ihh expression, which actually dropped below the 
control value at 20 μM SB203580.  However, 
Fig. 3 Modulation of Ihh mRNA expression pattern by RA and/or retinoid antagonist. 
Day-7 cultures of prehypertrophic chondrocytes were exposed to 100 nM RA or to 
retinoid antagonist at the indicated concentrations for 24 h in DMEM containing 
0.5% FBS. Total RNA from these cells was used for Northern blot analysis for Ihh. 
Representative Northern blots and control 18s (top) and quantiﬁcation of 3 experi-
ments after normalization to the control signals are shown (bottom). Asterisks indi-
cate signiﬁcant differences from the untreated cultures, at p ＜ 0.01 (＊).
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PD98059 did not affect the RA-induced Ihh ex-
pression.  Interestingly, RARγ expression was af-
fected in a manner quite similar to that of Ihh, 
with decreases seen during p38 inhibitor treat-
ment (data not shown). 
7. RA induces p38 MAPK activation in prehy-
pertrophic chondrocytes  
 To examine further the involvement of p38 
MAPK pathways in mediating the Ihh mRNA ex-
pression in prehypertrophic chondrocytes, we 
evaluated the activation of p38 MAPK after RA 
treatment.  As shown in Fig. 6A, p38 activated 
MAPK started to increase after treatment of RA 
and reached a maximum or plateau at 48 h. 
Ro41-5253 dose dependently inhibited the activa-
tion of p38 up-regulated by 100 nM RA, whereas 
Ro41-5253 did not inhibit the activation of endog-
enous p38 (Fig. 6B).  To clarify the phosphoryla-
tion of ATF-2 by p38 MAPK through the activation 
of p38 MAPK, we treated the cells with various 
concentrations of SB203580 along with 100 nM 
RA.  Treatment of the cells with SB203580 blocked 
both p38 and ATF 2 activity in a dose- dependent 
fashion (Fig. 6C).  The activity of p38 was not af-
fected by inhibition of ERK with PD98059 (data 
not shown).  These data indicated that the p38 
MAPK signal is important for RA-induced Ihh 
gene expression but not in the constitutive expres-
sion of Ihh.
8.  Effect of Ihh on the proliferation of the 
chondrocytes  
 Day-7 cultures of proliferating and hypertrophic 
chondrocytes were switched to low serum-contain-
ing medium for 24 h to induce mitotic quiescence. 
Cultures were then treated with rIhh-N for 24 hr, 
pulse-labeled with 5’-bromodeoxyuridine (BrdU) 
during the last 4 hr, and processed for BrdU incor-
poration.  As shown in Fig.7 A, N-Ihh dose depend-
ently promoted the proliferation of proliferative 
chondrocytes, whereas it had no effect on the pro-
liferation of hypertrophic chondrocytes.  It should 
be noted that Ihh mRNA induced by RA in prolif-
erating chondrocytes was hardly detected by 
Northern blot analysis in spite of RARγ gene ex-
Fig. 4 Decay of Ihh mRNA in the presence of actinomycin D and effect of cycloheximide on Ihh mRNA regula-
tion. (A) Cephalic chondrocytes (day 7) were incubated with or without 100 nM RA for 6 h, and de novo 
mRNA transcription was inhibited by the addition of actinomycin D (5 μg/ml). Total RNA was extracted 
at 2 and 4 h after administration of actinomycin D. The values in the graph indicate the percentage of 
initial Ihh mRNA signal remaining under these speciﬁc conditions. (B) Cycloheximide (25 μg/ml) was 
added to cells 1 h before the addition of RA to a ﬁnal concentration of 100 nM. After 6 h, total RNA was 
analyzed by Northern blotting. The values in the graph indicate the relative Ihh mRNA levels of cells 
stimulated with RA or not in the presence or absence of cycloheximide. The asterisk indicates a signiﬁ-
cant difference from untreated cells, at p ＜ 0.05 (＊).
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pression and RA induced p38 MAPK activation, 
whereas N-Ihh stimulated ptc-1 mRNA expression 
in the proliferating chondrocytes (data not shown). 
To determine whether the p38 MAP kinase, which 
was activated by RA, could regulate chondrocyte 
proliferation, we pulse-labeled chondrocytes with 
[3H] thymidine.  RA inhibited the proliferation of 
proliferating chondrocytes in a dose-dependent 
manner  (Fig. 7B).  The ERK inhibitor did not af-
fect the chondrocyte proliferation, which was in-
hibited by RA (Fig. 7C).  However, treatment with 
the p38 inhibitor reversed the RA inhibition of 
chondrocyte proliferation, giving an actual in-
crease over the control level at 1 μM SB203580 
(Fig. 7D).  On the other hand, RA did not affect 
the proliferation of hypertrophic chondrocytes 
(Fig. 7D).  Neither ERK nor p38 inhibitor affected 
the proliferation of hypertrophic chondrocytes 
(Fig. 7C and D).  The inhibition of chondrocyte 
proliferation by RA was rescued by the addition of 
N-Ihh (Fig. 7E).  These results provide evidence 
that RA-induced p38 MAPK activation may regu-
late the proliferation of proliferative chondrocytes 
directly to give a negative effect, or indirectly 
through Ihh secretion to give a positive effect (Fig. 
8).
Fig. 5 Analysis of the action of p38 MAPK in Ihh mRNA induction by RA. Day-7 cul-
tures of prehypertrophic chondrocytes were treated with increasing amounts of 
(A) or 20 μM (B) PD98059 or SB203580, and then stimulated with 100 nM RA for 
24 h. Ihh mRNA was detected by Northern blot analysis. Representative North-
ern blots and 18s ribosomal RNA and quantiﬁcation of 3 experiments after nor-
malization to the control signals are shown (bottom).
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Discussion
 The chick cephalic chondrocyte culture system 
exhibited Ihh expression depending on the culture 
day, showing a maximum in the prehypertrophic 
stage (Fig. 2).  This in vitro observation agrees 
with the up-regulation of Ihh expression during 
the prehypertrophic stage in mandibular condylar 
cartilage7.  The hedgehog protein families have 
been identiﬁed as key morphogens during skeletal 
development and regeneration19,21–23.  Among 
hedgehog proteins, Sonic hedgehog is involved in 
early limb patterning, whereas Ihh is involved in 
late limb development by regulating chondrocyte 
proliferation and differentiation9,24.  
 Wu et al. reported that RA down-regulates the 
Ihh gene and further up-regulates Shh indicates 
that RA would push the maturing chondrocytes 
toward the hypertrophic stage and favor bone for-
mation25.  They speculated that RA could produce 
different responses of the two hedgehog genes to 
RA, thus helping to clarify the complex interrela-
tionships that exist between endogenous and ex-
ogenous factors during growth cartilage develop-
ment and skeletal morphogenesis.  We showed 
here that Ihh was induced by RA in prehypertro-
phic chondrocytes and functioned in a paracrine 
manner to cause proliferation of chondrocytes in 
growth cartilage.  Although it is well established 
Fig. 6 RA effects on p38 MAPK. Day-7 cultures of prehypertrophic chondro-
cytes were exposed to 100 nM RA for the indicated times (A), 100 nM RA 
plus the indicated concentrations of retinoid antagonist for 24 h (B), or 
the indicated concentrations of SB203580 and 100 nM RA for 24 h (C). 
Cells were lysed, and protein extracts were analyzed by Immunoblot 
blot. The levels of activated p38 and ATF-2 were determined by using 
phosphospeciﬁc antibodies, which are indicated as p-p38 and p-ATF2. As 
controls, levels of total p38 were determined with speciﬁc antibodies. 
The data represent a typical experiment conducted more than 3 times 
with similar results.
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Fig. 7 Effect of Ihh, RA, and MAPK inhibitors on the chondrocyte proliferation. (A) Day-7 cultures of proliferating and hyper-
trophic chondrocytes were exposed to the indicated concentrations of Ihh at 0.01-10 μg/ml, and pulsed with bromode-
oxyuridine (BrdU) for the last 4 h. Day-7 cultures of proliferating (B-E) and hypertrophic (B-D) chondrocytes were treat-
ed with 1-1000 nM RA (B), 100 nM RA and 0-20 μM PD98059 (C), 100 nM RA and 0-20 μM SB203580 (D) or 10 μg/ml 
IHH, 100 nM RA and 10－7 M retinoid antagonist (Ro) and 10 μM SB203580 (E) for 24 h, and given [3H] thymidine for 
the last 4 h. Each point shows the mean value and S.D. for triplicate cultures, which are representative of the results 
from 3 experiments. Asterisks indicate differences between untreated cells and cells treated with the indicated agents,  
p ＜ 0.05 (＊).
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that Ihh plays an important role in regulating 
cartilage formation, it is not well known how 
Ihh itself is induced.  We showed here that one of 
the induction signals was mediated from RA via 
RARγ.  The Ihh mRNA level was increased 2-fold 
over the control, which makes RA one of the most 
Ihh-inductive genes.  This induction may be de-
pendent on RARγ in the prehypertrophic chondro-
cyte, since the RA antagonist Ro 41-5253, speciﬁc 
for RARγ in the hypertrophic chondrocyte26, abol-
ished the increase in Ihh mRNA level caused by 
RA (Fig. 3).  Quantitative analysis suggests that 
p38 MAPK inhibition strongly suppressed the ex-
pression of Ihh induced by RA.  The factors con-
trolling p38 MAPK activity during cartilage devel-
opment are not well known.  Members of the TGF-
β family27, FGFs28, CTGF/CCN229, and integrin30 
are known to activate p38 MAPK in developing 
chondrocytes.  In most cases, it is not clear how 
activation of p38 MAPK in response to these fac-
tors might contribute to cartilage development. 
Some of these effects of p38 MAPK signaling on 
hypertrophic gene expression appear to require 
ATF-2, a well-established transcription factor31. 
Genetic models support the important role of 
ATF-2 in skeletal development.  Homozygous mice 
expressing a mutant form of this transcription fac-
tor are runted and have altered growth plate mor-
phology similar to that observed in human hypo-
chondrodysplasia32.  Thus, it is safe to conclude 
that by controlling expression of transcription fac-
tors such as ATF-2 and the important downstream 
effector Ihh, retinoid signaling may represent a 
central player in the deﬁnition and orchestration 
of cellular and molecular functions needed by pre-
hypertrophic and hypertrophic chondrocytes to ex-
ert their fundamental roles in endochondral ossiﬁ-
cation.
 The action of RA is mediated via nuclear recep-
tors.  After binding to a nuclear receptor, RA can 
directly bind to the promoters of targeted genes, 
and then enhance transcription and translation. 
Recently, studies have demonstrated that RA in-
duces activation of MAPK and PI3 kinase in dif-
ferent cell models, despite the fact that the precise 
mechanism by which RA induces these pathways 
remains to be determined33–35.  Our results showed 
that RA activates p38 MAPK in a time-dependent 
manner (Fig. 6), resulting in the up-regulation of 
Ihh mRNA expression.  To explain how RA acti-
vates p38 MAPK, we considered several possible 
mechanisms.  Since RA, a lipophilic molecule, 
freely diffuses across plasma membranes, direct 
MAPK activation by RA would be rapidly induced. 
Most of the MAPK phosphorylation by extracellu-
lar ligands are elicited within 30 min36,37.  Our re-
sults show that p38 MAPK phosphorylation 
peaked at 24 h after treatment with 100 nM RA. 
The peak time after activation was not observed to 
be a short time after RA treatment.  Although we 
have not found the precise MAPK-dependent sig-
nal pathway, our results indicate that RA enhanc-
es the expression of Ihh mRNA through complex 
mechanisms; these may include the activation of 
upstream molecules of p38 MAPK, as well as in-
creased activation of transcription factor or coacti-
vator of the retinoid receptor by activated p38. 
Fig. 8 A schematic diagram depicting the role of p38 
MAPK activation induced by RA in proliferation 
of chondrocytes. RA inhibits the proliferation of 
proliferative chondrocytes through p38 MAPK 
activation. In contrast, activation of p38 MAPK 
induced by RA causes expression of Ihh in pre-
hypertrophic chondrocytes. RA-induced p38 
MAPK activation may regulate the proliferation 
of proliferative chondrocytes directly to give a 
negative effect or indirectly through Ihh secre-
tion to give a positive effect.
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Further investigations are needed to sort out 
these possibilities.
 RA induction of cell differentiation is usually ac-
companied by reduced cell proliferation, due to 
suppression of cell-cycle progression38,39.  The 
growth suppressive activity of RA in chondrocyte 
cells was RARγ dependent.  Although the mecha-
nism for growth suppression by RA is not yet cer-
tain, several possibilities have been investigated. 
One of them is that RA suppresses the transform-
ing growth factor-β pathway40.  Many studies 
have also indicated that RA treatment inhibits 
AP-1 activity41 and c-Fos expression42.  Recent evi-
dence indicates that the ERK2 MAPK is activated 
by RA in HL-60 cells and mediates the induction 
of cell differentiation and growth arrest43.  P38 
and ERK-1/2 act as positive and negative regula-
tors of chondrogenesis, respectively, by conversely 
regulating the expression of cell-adhesion mole-
cules44.  We conﬁrmed that RA activated ERK 
MAPK in prehypertrophic chondrocytes in a dose- 
and time-dependent manner (data not shown).  In-
terestingly, inhibition of the ERK MAPK pathway 
activated by RA did not affect the proliferation of 
proliferative chondrocytes, indicating that the 
ERK MAPK pathway was not involved in the RA-
inhibited proliferation.  In contrast, the inhibition 
of p38 MAPK abolished the RA inhibitory effect on 
the proliferation of proliferative chondrocytes in a 
dose-dependent manner.  The mechanism respon-
sible for the RA-elicited increase in p38 MAPK ac-
tivation is unclear.  However, we concluded that 
activated p38 MAPK plays a positive role in RA 
suppression of chondrocyte proliferation.
 In summary, our study presents an important 
intracellular pathway for RA signaling in prehy-
pertrophic chondrocytes.  This pathway links ex-
tracellular RA/RARγ signals to intracellular regu-
latory molecules, including p38 MAPK and 
ultimately to the regulation of Ihh mRNA expres-
sion in prehypertrophic chondrocytes that sepa-
rate proliferating cells from hypertrophic cells in 
the growth plate (Fig. 8).  RA-mediated IHH sig-
naling is crucial for the development of mandibu-
lar condylar cartilage. 
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